The page is the record's research on the issuer — no analyst, no rating, no view.

AVACTA GROUP PLC (AVCT) — research page

UK · uk-cm-kg/AIM/AVCT · as of 2026-11-06

Identity and listing

The issuer is AVACTA GROUP PLC, listed on AIM under ticker AVCT, with ISIN GB00BYYW9G87 and LEI 2138009U3EG31OPMGH36. Its security type is Corporate and its segment is ASQ1. Its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.

fieldvaluesource · read date
nameAVACTA GROUP PLCsource · 2026-11-06
exchangeAIMsource · 2026-11-06
tickerAVCTsource · 2026-11-06
ISINGB00BYYW9G87source · 2026-11-06
LEI2138009U3EG31OPMGH36source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentASQ1source · 2026-11-06
sectorPharmaceuticals and Biotechnology [201030]source · 2026-11-06
jurisdictionEngland and Wales (Companies House jurisdiction field)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 80 filings across 59 filing days in the twelve months from 2025-11-06 to 2026-11-06. The median gap between filing days is 3.0 days. The latest filing is dated 2026-11-04, a regulatory_announcement, two days before the record date of 2026-11-06. For AIM the median cadence gap is 7.0 days, the median filings count is 33.5 and the median latency is 4 days across 594 issuers. For the sector the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days across 51 issuers.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer8032
exchange median: AIM (594 issuers)33.574
sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers)4264
datetypecategoryfiling
2026-11-04regulatory_announcementTo Present pre|CISION® Dual Payload Candidate
2026-11-02regulatory_announcementJefferies Global Healthcare Conference
2026-10-26regulatory_announcementPFS Nearly Doubles with Faridoxorubicin Treatment
2026-10-26newswire_releaseAvacta Group plc: Faridoxorubicin Treatment Results in Near
2026-10-23regulatory_announcementHighlights pre|CISION® Platform Data

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is BDO LLP. The auditor's location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.

Orderability

For elective professional client the outcome is signal ACM-200, determinable. For eligible counterparty the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
elective professional clientACM-200
eligible counterpartyACM-200

rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The field has not been read, so the research houses named on the issuer's investor-relations page are not recorded.

Open research

The field has not been read, so openly published research notes are not recorded.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The vintage is not sealed and no issuer years are sealed as served. The market's earliest sealed date is not on the record. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.

Sources

10 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
10.2
https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/AVCT (identity.isin)
10.3
https://find-and-update.company-information.service.gov.uk/company/04748597 (identity.jurisdiction)
10.4
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.5
https://www.londonstockexchange.com/stock/AVCT/avacta-group-plc/company-page (identity.sector)
10.6
https://mcp.uk-cm-kg.ai/events/AIM/AVCT (the disclosure lines)
10.7
https://marketsecurities.fca.org.uk/officiallist (the halt flag)
10.8
https://avacta.com/wp-content/uploads/2026/05/Annual-Report-and-Accounts-31-December-2025.pdf (the auditor)
10.9
https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
10.10
https://mcp.uk-cm-kg.ai/record/AIM/AVCT (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"GB00BYYW9G87"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:25fad4c793a75671.